acyanotic in Vietnamese

Không xanh tím.

Sentence patterns related to "acyanotic"

Below are sample sentences containing the word "acyanotic" from the English - Vietnamese Medical Dictionary. We can refer to these sentence patterns for sentences in case of finding sample sentences with the word "acyanotic", or refer to the context using the word "acyanotic" in the English - Vietnamese Medical Dictionary.

1. Groups were equally balanced between cyanotic and acyanotic patients

2. These requirements were comparable among younger and older as well as cyanotic and acyanotic patients.

3. The patient collective represented all types and grades of severity of cyanotic and acyanotic CHD.

4. Cyanotic vitum is statistically more frequent in disturbances of rhythm to 35,7% than acyanotic vitium.

5. Initially, cyanotic children demonstrated a greater Pa-etCO2 compared with acyanotic children (P<0.05).

6. Of them, 63% were acyanotic; 68% of all operations became necessary during the first 6 months of life.

7. There was no difference in the Pa-etCO2 over time in the control, acyanotic-shunting, or mixing groups.

8. Children with cyanotic congenital heart disease showed similar pH andPaCO2 to acyanotic childrenfollowing administration of the short-acting barbiturate.

9. Thirteen children with acyanotic CHD and 12 children with cyanotic CHD were studied and compared with 28 children without heart disease (control).

10. Of the 686 heart-operations carried out in the past 6 1/2 years the congenital acyanotic heart defects are separately examined.

11. In contrast, patients with cyanotic CHD but normal urinary albumin concentrations and patients with acyanotic CHD had no overt renal impairment after cardiopulmonary bypass.

12. Acutenesses acuter acutes acutest: acutifoliate acutilobate acuting acyanoblepsia acyanophilous acyanotic acyclic acyclic acid acyclic compound acyclic monoterpene primary alcohol - NADP oxidoreductase: Literary usage of Acuteness

13. Pulmonary artery banding could be performed in all acyanotic malformations with a mortality rate of 17 % and of 12.5 % in isolated VSD (including debanding and VSD closure in several cases).

14. Forty children with CHD were studied: ten children with no interchamber communication and normal pulmonary blood flow (PBF) (normal group); ten acyanotic children with increased PBF (acyanotic-shunting group); ten cyanotic children with mixing type lesions and normal or increased PBF (mixing group), and ten cyanotic children with right-to-left intracardiac shunts demonstrating decreased and variable PBF (cyanotic-shunting group).

15. Studies were made of 13 hearts of infants and children with cyanotic congenital heart disease, 12 hearts with acyanotic congenital heart disease and 11 normal hearts.

16. We prospectively studied urinary protein concentration in 6 patients with cyanotic CHD and 4 patients with acyanotic CHD before and during a 3 day-period after surgery.

17. We conclude that the Pa-etCO2 of children with acyanotic-shunting and mixing congenital heart lesions is stable intraoperatively, although patients with mixing congenital heart lesions may demonstrate large individual variations.

18. The physical working capacity of 12 children with central or peripheral cyanosis was on the average considerably reduced. 25 children with acyanotic vitia showed on the average a normal working capacity.

19. The diagnosis can only be made by cardiac catheterisation and angiocardiography. Other conventional methodes of assessement do not allow differentiation from ventricular septal defect, pulmonic stenosis and acyanotic or cyanotic forms of tetralogy ofFallot.

20. Fifteen children with left to right intracardiac shunting of blood (acyanotic group) and 15 children with right to left intracardiac shunting of blood (cyanotic group) were studied and compared with 15 children without CHD (control group).

21. Urinary excretion of albumin, immunoglobulin G, transferrin, soluble L-selectin, α1-microglobulin, and β-N-acetyl-glucosaminidase remained normal throughout the postoperative period in acyanotic CHD patients and rose slightly in cyanotic CHD patients without acute renal failure.

22. Blood coagulation was examined in a series of 35 children with cyanotic and 66 children with acyanotic congenital cardiac anomalies. Comparison with a control group of children without heart disease demonstrated the following differences: Only patients with cyanosis had higher haematocrit and lower thrombocyte values.

23. Primary mortality of the total of interventions amounted to 6,41%, that after corrections of open defects to 5,73% and that after interventions on one or more cardiac valves to 15,68%, including reoperation. 118 open corrections because of acyanotic heart defects of children younger than 14 were carried out without any fatal issue.

24. To assess blood coagulation and fibrinolytic activity in congenital heart disease, the platelet count, plasma clotting times (thromboplastin time, partial thromboplastin time, thrombin time) as well as the coagulation (thrombelastography) and activity of the proactivator-plasminogen-complex of whole blood were determined prospectively in 500 patients; 55% of whom had acyanotic and 45% cyanotic lesions.

25. In acyanotic congenital heart disease all values were within normal limits. In contrast, in the cyanotic group, the average platelet count, the coagulation of plasma and whole blood as well as the fibrinolytic activity showed a decreasing tendency with increasing age. Regardless of the type of lesion, the lowest values, attributable to immature coagulation systems, were observed in newborns.

26. RSV prophylaxis with palivizumab, if undertaken, should be initiated at the start of the RSV season and continued monthly until the end of the season. Palivizumab is not indicated for the inpatient treatment of established RSV infection. Children less than 2 years of age with hemodynamically significant cyanotic or acyanotic congenital heart disease (who require corrective surgery or are receiving cardiac medication for hemodynamic considerations) should be considered for monthly palivizumab prophylaxis during the winter season.